title: Ultralow concentrations of proenkephalin and [met5]-enkephalin differentially affect IgM and IgG production by B cells.
abstract: Resting mouse splenic B cells were activated with lipopolysaccharide/dextran sulfate (LPS/DxS) to measure both B cell proliferation and IgM/IgG isotype production when increasing concentrations of [Met5]-enkephalin (MENK) and proenkephalin (PENK) (10-16 to 10(-8) M) were added at increasing times after B cell activation (0, 3, 6, or 24 h). Results show that proliferation was not affected by either peptide, but that IgM, IgG3 and IgG2a production were inhibited in a concentration- and time-dependent manner by MENK. IgG1 production was unaffected by MENK. In contrast, PENK induced no change in the production of Ig isotypes at any time point of addition, with the exception of IgG1 and IgG2a that were enhanced when PENK was added 6 h after cell activation. In the absence of LPS/DxS activation, no change in the level of any Ig isotype was induced by either peptide.
authors.affiliation: Systems Toxicology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
authors.forename: K P
authors.initials: KP
authors.lastname: Das
authors.forename: J S
authors.initials: JS
authors.lastname: Hong
authors.forename: V M
authors.initials: VM
authors.lastname: Sanders
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D002455:Cell Division / Q000187:drug effects; D016264:Dextran Sulfate / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004744:Enkephalin, Methionine / Q000008:administration & dosage* / Q000494:pharmacology; D004745:Enkephalins / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D007074:Immunoglobulin G / Q000096:biosynthesis*; D007075:Immunoglobulin M / Q000096:biosynthesis*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009994:Osmolar Concentration; D011498:Protein Precursors / Q000008:administration & dosage* / Q000494:pharmacology
chemical_list: D004745:Enkephalins; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008070:Lipopolysaccharides; D009292:Narcotic Antagonists; D011498:Protein Precursors; C029992:proenkephalin; D009270:Naloxone; D004744:Enkephalin, Methionine; D016264:Dextran Sulfate